BioHarvest Sciences stock | 2026 forecast, price target & growth

BioHarvest Sciences

NasdaqGM:BHST

C$ 4,38

+ C$0,03 (0,69%)

4,38 C$

+C$0,03 (0,69%)

End-of-day quote: 04/24/2026

BioHarvest Sciences Stock Value

The analyst rating for NasdaqGM:BHST is currently Buy.

Buy

BioHarvest Sciences Company Info

EPS Growth 3Y

28,70%

Market Cap

C$0,10 B

Long-Term Debt

C$0,00 B

Short Interest

0,00%

Quarterly earnings

05/14/2026

Dividend

C$0,00

Dividend Yield

0,00%

Founded

Data Unavailable

Industry

Health Care

Country

Canada

ISIN Number

CA09076J2074

Website

http://www.bioharvest.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

C$17,79

306.16%

Last Update: 04/24/2026

Analysts: 4

Highest Price Target C$20,52

Average Price Target C$17,79

Lowest Price Target C$13,68

In the last five quarters, BioHarvest Sciences’s Price Target has fallen from C$28,72 to C$20,34 - a -29,18% decrease. Three analysts predict that BioHarvest Sciences’s share price will increase in the coming year, reaching C$17,79. This would represent an increase of 306,16%.

Top growth stocks in the health care sector (5Y.)

What does BioHarvest Sciences do?

BioHarvest Sciences Inc. operates as a biotechnology company. The company primarily focuses on the research, development, manufacturing, marketing, and sale of scientifically based therapeutic solutions. Business Segments The company operates in multiple business segments. The primary segments are: Nutraceuticals Nutraceutical segment involves the research, development, manufacturing, marketing, and sale of health supplements that offer health benefits beyond basic nutrition. The company pro...

Business Segments

The company operates in multiple business segments. The primary segments are:

Nutraceuticals

Nutraceutical segment involves the research, development, manufacturing, marketing, and sale of health supplements that offer health benefits beyond basic nutrition. The company produces therapeutic solutions aimed at improving health outcomes through natural ingredients. The formulation process is heavily grounded in scientific research, ensuring efficacy and safety for consumers. This segment seeks to harness the potential of plant-based nutrients, cultivating a product line that echoes wellness trends aligned with modern health consciousness.

Pharmaceuticals

Pharmaceuticals segment, the company focuses on developing plant cell-based Active Pharmaceutical Ingredients (APIs). This segment embraces innovative technologies to produce pharmaceutical components that are consistent, controlled, and free of harmful chemicals. The company’s proprietary Botanical Synthesis platform technology enables the production of pharmaceuticals in a sustainable manner, adhering to stringent industry standards. The application of this technology is pivotal for developing treatments for specific medical indications, allowing the company to address unmet medical needs effectively.

Business Strategy

The business strategy of the company centers on leveraging innovative technologies to deliver high-quality products in both the nutraceutical and pharmaceutical sectors. The company aims to establish itself as a leader in developing scientifically backed, plant-based therapeutic solutions that cater to a growing consumer demand for natural health products.

By prioritizing R&D, the company strives to enhance its product offerings through continuous innovation and exploration of advanced methodologies in plant cell technology. This commitment to innovation is reflected in the company's active pursuit of patents, ensuring that its proprietary processes and products are safeguarded and distinct within the competitive landscape.

Additionally, the company focuses on building strategic partnerships that are essential for expanding its market reach and augmenting capabilities. Collaborations with key stakeholders, including research organizations, will complement the company's in-house capabilities, providing access to state-of-the-art technology and expertise.

Furthermore, the company engages in rigorous market analysis and consumer insights to tailor its offerings to the needs of its target demographic. By aligning product development with consumer trends and preferences, the company enhances its market positioning, creating a robust framework for sustainable growth.

Products and Services

The company offers a range of products and services within the nutraceutical and pharmaceutical sectors.

In the Nutraceutical segment, the company focuses on health supplements derived from natural plant-based ingredients. Therapeutic solutions designed to foster holistic wellbeing and target specific health concerns. Integration of scientific research into product formulation to promote health outcomes backed by empirical data.

In the Pharmaceutical segment, the company engages in the development of plant cell-derived APIs which serve as core components for various medicinal formulations. Innovations via its botanical synthesis platform that ensures the production processes are aseptic and chemical-free, greatly contributing to product integrity and efficacy. Patented technologies that ensure uniqueness and legal protection of the developed products.

The company also provides Contract Development and Manufacturing Operations services, offering its expertise in product development and manufacturing for external clients.

Geographical Markets Served

The company primarily serves customers in Israel and the USA. The geographical emphasis on these markets allows the company to tap into diverse consumer bases, thereby enhancing its growth opportunities and market presence.

Customers

The company serves a diverse range of customers across health-focused sectors. This includes individuals seeking wellness solutions, healthcare providers, and potentially, pharmaceutical companies looking to procure API components. The company's customer base spans from retail markets to specialized healthcare entities, highlighting its versatile reach within the health and wellness industry.

Modes of Sales and Marketing

The company implements a multifaceted sales and marketing approach to reach its customers effectively. The company's marketing efforts encompass digital channels, including social media, online advertising, and health-focused platforms. Direct marketing strategies aim to engage consumers by providing educational content that underscores the benefits of its products. In terms of distribution, the company has established partnerships with various retail outlets and online marketplaces to facilitate product accessibility.

New support ticket

Explore

BioHarvest Sciences Stock Value

BioHarvest Sciences Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does BioHarvest Sciences do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

BioHarvest Sciences Stock Value

BioHarvest Sciences Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does BioHarvest Sciences do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.